Inicio・Lista de Acciones・Omnicell Inc

Omnicell Inc

Cerrado

SectorSanidad

33.65 2

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

32.54

Máximo

33.71

Métricas clave
By Trading Economics
Ingresos	13M 24M
Ventas	2.3M 312M
P/B Media del Sector	38.607 55.725
BPA	0.7
Margen de beneficios	7.78
Empleados	3,485
EBITDA	-22M 14M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+66.52% upside

Dividendos
By Acuity
Próximas Ganancias	29 oct 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-412M 1.5B
Apertura anterior	31.65
Cierre anterior	33.65

Omnicell Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

25 sept 2026, 22:40 UTC

Omnicell Inc is experiencing a notable increase in after-market trading, advancing from Friday's close and reflecting unusual activity for this time of day.

24 sept 2026, 23:50 UTC

Omnicell Inc is trading lower in after-market hours, reflecting broader market declines amid rising U.S. Treasury yields and inflation concerns.

23 sept 2026, 23:35 UTC

Omnicell Inc's stock is declining in after-market trading, remaining below its 20-day moving average despite a modest recovery from earlier lows.

22 sept 2026, 23:01 UTC

Omnicell Inc is trading modestly higher in after-market hours, continuing a trend of three consecutive sessions that have closed higher.

18 sept 2026, 19:46 UTC

Omnicell Inc shares fell sharply, retracing from a brief pre-market rise and remaining under pressure near the lower end of its one-month range.

16 sept 2026, 19:16 UTC

Omnicell Inc shares fell sharply, currently trading below the 20-day moving average and near the lower end of their one-month range.

15 sept 2026, 22:51 UTC

Omnicell Inc shares are higher in after-market hours, tracking broader market gains. The stock remains below its 20-day moving average amid subdued performance.

14 sept 2026, 19:46 UTC

Omnicell Inc is higher in Monday's session, reaching a session high earlier. Market conditions reflect rising crude oil prices and anticipated Fed interest rate hikes.

11 sept 2026, 21:01 UTC

Omnicell Inc. shares are higher in after-market hours, despite a lack of specific news and broader market weakness. The stock remains near its one-month trading range.

10 sept 2026, 20:03 UTC

Omnicell Inc. shares are lower today, breaking a trend of higher closes since Wednesday amid macroeconomic developments, including the European Central Bank's interest rate hike.

4 sept 2026, 20:07 UTC

Omnicell Inc. shares are lower today, continuing a decline since Thursday amid broader market pressure following a strong jobs report.

3 sept 2026, 23:11 UTC

Omnicell Inc. shares are lower in after-market hours, trading below their 20-day moving average and near the lower end of their one-month range.

2 sept 2026, 20:08 UTC

Omnicell Inc is advancing today, supported by gains in the Health Care Equipment sub-sector. Earlier, the stock pulled back from a session high.

1 sept 2026, 20:09 UTC

Omnicell Inc. shares are lower today amid broader market declines, influenced by rising oil prices and inflation concerns affecting investor sentiment.

31 ago 2026, 20:03 UTC

Omnicell shares are higher today, continuing a strong advance since Friday's close, despite no specific company news.

28 ago 2026, 20:07 UTC

Omnicell Inc. shares are lower amid rising U.S. Treasury yields and inflation concerns, contributing to a broader market decline during Friday's session.

27 ago 2026, 23:56 UTC

Omnicell Inc. shares are higher in after-market trading, despite lacking specific company news. Recent economic data continues to influence market sentiment.

26 ago 2026, 23:01 UTC

Omnicell Inc shares are higher in after-market trading, continuing an upward trend despite being below their 20-day moving average and near one-month lows.

25 ago 2026, 23:26 UTC

Omnicell Inc. shares are higher in after-market trading, recovering from earlier lows despite remaining below the 20-day moving average.

21 ago 2026, 19:26 UTC

News

Omnicell shares are higher as analysts issue mixed target price updates. Piper Sandler lowered its target to $45, while KeyCorp reduced its target to $65.

19 ago 2026, 19:26 UTC

Omnicell Inc shares are higher during Wednesday's session, showing upward momentum despite trading below the 20-day moving average. No specific news was identified.

18 ago 2026, 22:51 UTC

Omnicell Inc shares are lower in after-market hours, reflecting broader negative sentiment amid rising sovereign bond yields and inflation concerns.

17 ago 2026, 23:36 UTC

Omnicell shares are higher in after-market trading, gaining after closing up on Monday. The broader market showed mixed performance amid rising crude oil prices.

14 ago 2026, 23:01 UTC

Omnicell Inc shares rose in after-market trading, recovering from an early low. The stock remains below its 20-day moving average.

12 ago 2026, 19:41 UTC

News

Omnicell shares are higher amid positive sentiment ahead of management's meetings with KeyBanc in Philadelphia and New York this month.

11 ago 2026, 22:16 UTC

Omnicell Inc shares are higher in after-market trading, with no specific news identified. Market focus remains on inflation data and Federal Reserve interest rate hikes.

10 ago 2026, 19:16 UTC

News

Omnicell Inc reported second-quarter revenue of $312.21 million and upgraded its guidance, contributing to shares trading higher since Friday's close.

7 ago 2026, 23:16 UTC

Omnicell Inc shares are rising in after-market trading, reflecting broader market dynamics following a disappointing jobs report that reduced interest rate hike expectations.

6 ago 2026, 23:21 UTC

Omnicell Inc's shares are higher in after-market trading, showing strength following Thursday's close amid broader market dynamics and upcoming economic data.

5 ago 2026, 22:02 UTC

Omnicell Inc shares are higher in after-market trading, continuing an earlier session advance. The stock remains below its 20-day moving average and one-month range.

Comparación entre iguales

Cambio de precio

Omnicell Inc previsión

Precio Objetivo

By TipRanks

66.52% repunte

Estimación a 12 Meses

Media 55 USD 66.52%

Máximo 65 USD

Mínimo 45 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Omnicell Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Omnicell Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.